Detailed Quote
| Previous Close | 0.3210 |
|---|
| Open | 0.3219 |
|---|
| Bid | 0.4455 |
|---|
| Ask | 0.4475 |
|---|
| Day's Range | 0.3140 - 0.4484 |
|---|
| 52 Week Range | 0.1806 - 2.482 |
|---|
| Volume | 36,578,788 |
|---|
| Market Cap | 40.49M |
|---|
| PE Ratio (TTM) | -0.1252 |
|---|
| EPS (TTM) | -3.5 |
|---|
| Dividend & Yield | N/A (N/A) |
|---|
| 1 Month Average Volume | 6,570,762 |
|---|
Chart
About Curis, Inc. - Common Stock (CRIS)
Curis Inc is a biotechnology company that focuses on the development of innovative therapeutics for the treatment of cancer. The company specializes in targeted therapies that aim to address the underlying mechanisms of cancer growth and progression, leveraging its expertise in small molecules and antibody therapies. Curis's research and development efforts are geared toward advancing novel treatment options for patients with various types of malignancies, with the goal of improving outcomes and enhancing quality of life. Through partnerships and collaborations, Curis seeks to bring its promising discoveries from the laboratory to the clinical setting, ultimately striving to address unmet medical needs in oncology. Read More
